SCHEMBL27504643

SCHEMBL27504643

CC(=O)Oc1ccc2cccc(O)c2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.54
LMNA P02545 1/20 0.50
CTDSP1 Q9GZU7 1/20 0.47
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
POLB P06746 2/20 0.46
KDM4E B2RXH2 1/20 0.46
GLA P06280 1/20 0.46
GAA P10253 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
ACHE P22303 1/20 0.46
MTNR1A P48039 5/20 0.45
MTNR1B P49286 3/20 0.45
HTR2C P28335 1/20 0.45
HTR2B P41595 1/20 0.45
CA2 P00918 3/20 0.44
GRIN2D O15399 1/20 0.44
GRIN2A Q12879 1/20 0.44
GRIN2B Q13224 1/20 0.44
GRIN2C Q14957 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16187157 0.87 CTDSP1 (0.45) CYP3A4CTDSP1POLBGAATDP1
SCHEMBL27529724 0.87 CYP3A4 (0.54) CYP3A4LMNACA12CA9KDM4E
SCHEMBL9610674 0.84 ELANE (0.47) CYP3A4CTDSP1MTNR1AMTNR1BHTR2C
SCHEMBL7079680 0.84 MTNR1A (0.48) CTDSP1MTNR1AMTNR1BHTR2CHTR2B
SCHEMBL29940384 0.83 KDM4E (0.50) CYP3A4LMNACA12CA9POLB
SCHEMBL10458103 0.83 LMNA (0.54) CYP3A4LMNACA12CA9POLB
SCHEMBL1143252 0.83 KDM4E (0.50) CYP3A4LMNACA12CA9POLB
SCHEMBL27497870 0.83 MAPT (0.50) CYP3A4LMNACTDSP1CA12CA9
SCHEMBL29257065 0.82 CYP3A4 (0.49) CYP3A4LMNACA12CA9POLB
SCHEMBL13888153 0.82 MTNR1A (0.54) MTNR1AMTNR1BHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1256326-C Novel 4- (oxoxyphenyl) -3-oxopiperidines for the treatment of cardiac and renal insufficiency HOFFMANN LA ROCHE (CH) 2006-05-17 CN disclosed
CN-1202152-A Novel 4- (oxoxyphenyl) -3-oxopiperidines for the treatment of cardiac and renal insufficiency HOFFMANN LA ROCHE (CH) 1998-12-16 CN disclosed